These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10079003)

  • 61. Effects of alniditan on neurogenic oedema in the rat dura mater and on contraction of rat basilar artery.
    Limmroth V; Bischoff A; Fetscher C; Wermelskirchen D; Diener H; Michel MC
    Eur J Pharmacol; 1999 Oct; 382(2):103-9. PubMed ID: 10528144
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
    Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery.
    MacLean MR; Clayton RA; Templeton AG; Morecroft I
    Br J Pharmacol; 1996 Sep; 119(2):277-82. PubMed ID: 8886409
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Saxena PR; De Vries P; Wang W; Heiligers JP; Maassen vandenBrink A; Bax WA; Yocca FD
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):295-302. PubMed ID: 9050026
    [TBL] [Abstract][Full Text] [Related]  

  • 65. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels.
    Humphrey PP; Fenvik W; Salonen R
    Neurology; 2001 Jul; 57(1):162-3. PubMed ID: 11445657
    [No Abstract]   [Full Text] [Related]  

  • 67. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
    MacLean MR; Sweeney G; Baird M; McCulloch KM; Houslay M; Morecroft I
    Br J Pharmacol; 1996 Nov; 119(5):917-30. PubMed ID: 8922741
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological characterisation of postjunctional 5-HT receptors in cerebral arteries from the sheep.
    Gaw AJ; Wadsworth RM; Humphrey PP
    Eur J Pharmacol; 1990 Apr; 179(1-2):35-44. PubMed ID: 2163850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 2-(2-Aminoethyl)-quinoline (D-1997): a novel agonist at 5-hydroxytryptamine1-like receptors in the canine basilar artery.
    Terrón JA; López-Muñoz FJ; Hong E; Villalón CM
    Arch Int Pharmacodyn Ther; 1994; 327(1):56-68. PubMed ID: 7944828
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Eletriptan: pharmacological differences and clinical results.
    Giffin N
    Curr Med Res Opin; 2001; 17 Suppl 1():s59-62. PubMed ID: 12463280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
    Cocks TM; Kemp BK; Pruneau D; Angus JA
    Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence that 5-HT2 receptors predominantly mediate the contraction of the rat basilar artery to 5-hydroxytryptamine.
    Deckert V; Angus JA
    Eur J Pharmacol; 1992 Oct; 221(1):17-25. PubMed ID: 1459189
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery.
    Geerts IS; Matthys KE; Herman AG; Bult H
    Br J Pharmacol; 1999 Jul; 127(6):1327-36. PubMed ID: 10455282
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
    Muñoz-Islas E; Gupta S; Jiménez-Mena LR; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
    Br J Pharmacol; 2006 Sep; 149(1):82-91. PubMed ID: 16880765
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists.
    De Ponti F; Crema F; Moro E; Nardelli G; Frigo G; Crema A
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G96-104. PubMed ID: 12646419
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
    Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
    Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum.
    Carter D; Champney M; Hwang B; Eglen RM
    Eur J Pharmacol; 1995 Jul; 280(3):243-50. PubMed ID: 8566092
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of 5-hydroxytryptamine receptors in rabbit isolated iliac artery.
    Yildiz O; Tuncer M
    Arch Int Pharmacodyn Ther; 1993; 326():72-83. PubMed ID: 8185415
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors.
    Longmore J; Razzaque Z; Shaw D; Davenport AP; Maguire J; Pickard JD; Schofield WN; Hill RG
    Br J Clin Pharmacol; 1998 Dec; 46(6):577-82. PubMed ID: 9862247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.